Neglected diseases

Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases

Retrieved on: 
Friday, June 4, 2021
Tropical diseases, Medical specialties, Neglected tropical diseases, Sanitation, Neglected diseases, Medicine, Clinical medicine

The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research.

Key Points: 
  • The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research.
  • Auransa is an AI-driven biotech company, with a pipeline of novel compounds for various diseases.
  • POLARISqb built the first drug discovery platform using quantum computing, making the process ten times faster.
  • We are thrilled to be able to combine our technology with Auransa's and tackle neglected diseases affecting women.

New Report Reveals that R&D Partnerships Serving Neglected Communities have Produced Dozens of Life-Saving Innovations Since 2010

Retrieved on: 
Thursday, January 28, 2021
Medical specialties, Articles, Tropical diseases, Government procurement, Public–private partnership, Neglected tropical diseases, Clinical medicine, Global health, Neglected diseases

However, the effectiveness of public-private partnerships in fighting global health threats had emerged long before this pandemic hit.

Key Points: 
  • However, the effectiveness of public-private partnerships in fighting global health threats had emerged long before this pandemic hit.
  • The report notes the stark contrast between the neglected disease product development space before and after the ascent of PDPs around the turn of the century.
  • Currently, the cumulative pipeline of the PDPs behind the report contains more than 375 new innovations, 25 percent of them now in late-stage development.
  • 1 Grace C. Product Development Partnerships (PDPs): Lessons from PDPs established to develop new health technologies for neglected diseases.

Rockford, Illinois, Ranks #1 in CAPC's Top 10 Cities HOOKWORM Report for June

Retrieved on: 
Thursday, July 9, 2020
Infectious diseases, Medical specialties, Medicine, Neglected diseases, Helminthiases, Tropical diseases, Strongylida, Ancylostomatidae, Hookworm infection, Hookworm, Helminthiasis, Ancylostoma duodenale

Pets can become infected by hookworm larvae penetrating the skin, licking paws, chewing contaminated toys, or ingesting infected prey such as mice.

Key Points: 
  • Pets can become infected by hookworm larvae penetrating the skin, licking paws, chewing contaminated toys, or ingesting infected prey such as mice.
  • In dogs, signs of hookworm infection may include dark, tarry diarrhea, anemia, loss of appetite, weight loss and skin lesions.
  • If not, they are allowing hookworm larvae to live in the environment, and hookworm eggs are hearty with the ability to live for months."
  • "It's our hope that the new CAPC Top 10 Cities HOOKWORM Report will prompt important conversations between pet owners and their veterinarians about hookworm protection."

Des Moines, Iowa, Ranks #1 in CAPC's Top 10 Cities HOOKWORM Report for May

Retrieved on: 
Tuesday, June 16, 2020
Infectious diseases, Medical specialties, Medicine, Neglected diseases, Helminthiases, Tropical diseases, Strongylida, Ancylostomatidae, Hookworm infection, Hookworm, Helminthiasis, Ancylostoma duodenale

Pets can become infected by hookworm larvae penetrating the skin, licking paws, chewing contaminated toys, or ingesting infected prey such as mice.

Key Points: 
  • Pets can become infected by hookworm larvae penetrating the skin, licking paws, chewing contaminated toys, or ingesting infected prey such as mice.
  • In dogs, signs of hookworm infection may include dark, tarry diarrhea, anemia, loss of appetite, weight loss and skin lesions.
  • If not, they are allowing hookworm larvae to live in the environment, and hookworm eggs are hearty with the ability to live for months."
  • "It's our hope that the new CAPC Top 10 Cities HOOKWORM Report will prompt important conversations between pet owners and their veterinarians about hookworm protection."

Chagas Disease Pipeline Insight, 2020: Therapeutic Assessment, Unmet Needs, Products, Drugs, Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, May 1, 2020
Health, Pharmaceutical, Infectious diseases, Medicine, Medical specialties, Tropical diseases, Neglected diseases, RTT, Chagas disease, Zoonoses, Chagas, Disease, Therapeutic assessment

A detailed picture of the Chagas Disease pipeline landscape is provided, which includes the disease overview and Chagas Disease treatment guidelines.

Key Points: 
  • A detailed picture of the Chagas Disease pipeline landscape is provided, which includes the disease overview and Chagas Disease treatment guidelines.
  • The assessment part of the report embraces in-depth Chagas Disease commercial assessment and clinical assessment of the Chagas Disease pipeline products from the pre-clinical developmental phase to the marketed phase.
  • Different therapeutic candidates segmented into early-stage, mid-stage and late stage of development for the Chagas Disease treatment.
  • Our in-depth analysis of the pipeline assets (in early-stage, mid-stage and late stage of development for the treatment of Chagas Disease) includes therapeutic assessment and comparative analysis.

Co-Diagnostics, Inc. Reports 2019 Year-End Financial Results and Progress Updates

Retrieved on: 
Tuesday, March 31, 2020
Health, Infectious diseases, Genetics, Other Science, General Health, Science, Infectious diseases, Medical specialties, Medicine, Neglected diseases, Tropical diseases, RTT, Epidemiology, Zika virus, Chikungunya, Zika fever, Dengue fever, Mosquito

Company launched its vector control vertical in mid-2019 and experienced growth in that sector throughout the year.

Key Points: 
  • Company launched its vector control vertical in mid-2019 and experienced growth in that sector throughout the year.
  • Products launched for the vector control vertical in 2019 to identify the presence of infectious diseases in mosquito populations included multiplex tests for Zika/dengue/chikungunya, West Nile/St.
  • The Company also sold Common Shares of its stock pursuant to a shelf offering for gross proceeds of approximately $5.5 million in Q1 2019.
  • Actual results may differ materially from those contemplated or anticipated by such forward-looking statements.

Co-Diagnostics, Inc. to Present its Rapid Response to New Coronavirus in Washington D.C. Conference

Retrieved on: 
Thursday, February 13, 2020
Health, Infectious diseases, Genetics, Research, Science, Biotechnology, Infectious diseases, Medical specialties, Medicine, Neglected diseases, Tropical diseases, RTT, Zika virus, Polymerase chain reaction, Chikungunya, Dengue fever, Zika fever, Coronavirus

The conference will take place on February 13-16, 2020 in Washington D.C.

Key Points: 
  • The conference will take place on February 13-16, 2020 in Washington D.C.
  • The Company will report how its proprietary design platform allowed Co-Diagnostics scientists to work quickly in response to the threat of the new strain of coronavirus.
  • In addition to its work on coronavirus, the Company will showcase its infectious disease initiative, which incorporates its vector control solutions that it began commercializing in 2019.
  • Co-Diagnostics Vector Smart assays include multiplex polymerase chain reaction (PCR) tests for Zika/dengue/chikungunya, and West Nile/St.

2020 Europe Enteric Disease testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio & Yersinia - ResearchAndMarkets.com

Retrieved on: 
Monday, January 27, 2020
Infectious diseases, Biotechnology, Health, Medical specialties, Infectious diseases, Medicine, Neglected diseases, Tropical diseases, Pathogenic bacteria, Campylobacter, Capnophiles, Epsilonproteobacteria, Enterovirus, Escherichia coli, Rotavirus

This new 363-page report from the author provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

Key Points: 
  • This new 363-page report from the author provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
  • This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK).
  • Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.
  • The report provides test volume and sales forecasts and market segment, including:
    In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country.

Global Mosquito Repellent Market - Opportunities and Forecast (2019-2024)

Retrieved on: 
Wednesday, January 8, 2020
Infectious diseases, Medical specialties, Medicine, Tropical diseases, Vaccine-preventable diseases, RTT, Neglected diseases, Mosquito, Insect repellent, Malaria, Dengue fever, Mosquito net

Global Mosquito Repellent Market was valued at USD 4637 Million in the year 2018.

Key Points: 
  • Global Mosquito Repellent Market was valued at USD 4637 Million in the year 2018.
  • Certain countries including Brazil, Colombia, Vietnam, Philippines, Cambodia, Singapore, Malaysia, Thailand witnessing disease outbreak and resilient domestic demand coupled with rising personal healthcare expenditure and rapidly surging number of patients suffering from various mosquito transmitted diseases like Dengue, Malaria and Encephalitis, which has accelerated the mosquito repellent market growth during the period of 2019-2024.
  • In addition, rising investment by major leading Mosquito Repellent manufacturers in various regions with enhanced availability of Mosquito Repellents and focus of government on educating consumers about healthy impact of using mosquito repellent with various government powered awareness programmes that are being run with an aim to eradicate diseases, has been anticipated to spur the market growth during the forecast period.
  • Global Mosquito Repellent Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

New Orleans Apparel Brand Introduces Bug Repellent Travel Wraps As Dengue Fever Outbreaks Prompt Third CDC Travel Alert

Retrieved on: 
Friday, January 3, 2020
Infectious diseases, Medical specialties, Hiking equipment, Medicine, Neglected diseases, Tropical diseases, Insect repellents, Vaccine-preventable diseases, Dengue fever, Mosquito-borne disease, Mosquito, Insect Shield

One of the most common New Year's resolutions brings increased challenges for travelers in 2020, with the alarming rise of dengue fever worldwide.

Key Points: 
  • One of the most common New Year's resolutions brings increased challenges for travelers in 2020, with the alarming rise of dengue fever worldwide.
  • In response to the threat of dengue and other diseases spread by insects, New Orleans-based Pang Wangle has partnered with Insect Shield to transform their travel wraps and leggings into wearable bug repellent.
  • "We find that most people haven't heard of bug repellent clothes," says Pang Wangle founder and CEO Jennifer John.
  • Florida remains under a mosquito-borne illness alert after two new cases of dengue fever were transmitted locally in Miami.